Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia

AstraZeneca339 enrolled

Overview

This study is a 6-month, multicenter, randomized study to assess the effect of daily SMS reminders sent during 3 months in the adherence to oral antipsychotic treatment in stabilized outpatients with schizophrenia.

Study Type

OBSERVATIONAL

Enrollment

339

Conditions

Schizophrenia

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male or female patients older than 18 years * With a diagnosis of schizophrenia (DSM-IV TR criteria) * Stabilized out-patients * Under oral antipsychotic monotherapy Exclusion Criteria: * Administration of a depot antipsychotic drug * Suicide risk

Locations (25)

Research Site

Alicante, Alicante, Spain

Research Site

Almería, Almeria, Spain

Outcomes

Primary Outcomes

Morisky Green Questionnaire

Time frame: baseline, at months 3 and 6

Secondary Outcomes

Clinical Global Impression- Schizophrenia (CGI-SCH)

Time frame: baseline, at months 3 and 6

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.